List view / Grid view

Search results for Vaccine-induced%20prothrombotic%20immune%20thrombocytopenia:%20pathogenetic%20and%20epidemiological%20issues%20of%20concern - 3882 results

 

Showing results for vaccine induced prothrombotic immune thrombocytopenia pathogenetic 20and epidemiological issues 20of concern vaccine induced vaccine-induced pathogenetic 20and issues 20of

Whitepapers/App Notes/Posters

Whitepaper: Multiplexed cancer immune response analysis nCounter® PanCancer Immune Profiling Panel for gene expression

1 October 2015 | By

The ability of mutated cells to give rise to pathological cancer relies upon the capability of these cells to evade immune recognition, suppress immune activity, and persist in a chronically inflamed environment. Tremendous growth in the understanding of these complex processes is beginning to generate breakthroughs in the treatment of…

news

Panacea initiates Phase I prostate cancer vaccine therapy trial

19 January 2017 | By Niamh Marriott, Digital Editor

Panacea Pharmaceuticals have enrolled and dosed the first patient in the open-label, parallel designed, multi-centre Phase I clinical trial of PAN-301-1, for the treatment of persistent prostate cancer to assess safety and immunogenicity. Clinical sites for the PAN-301-1 trial are located in Alabama, California, Nebraska and South Carolina and the…